Europe Colistin Market Analysis and Forecast by Size, Share, Growth, Trends 2034
Europe Colistin Market Size and Forecast (2021 - 2034), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Formulation (Injectables (IV or IM), Oral, Topical Formulations, and Inhalation Solutions), Indication (Human Health and Animal Health), Human Health (Bloodstream Infections (BSI) and Sepsis Lower, Respiratory Tract Infections (LRTI), Urinary Tract Infections (UTIs), Central Nervous System Infections, Skin Infections, Cystic Fibrosis, Tracheobronchitis or VAP, Gastrointestinal Infections, and Bowel Decontamination), and Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Channel, and Other Distribution Channel)
- Status : Published
- Report Code : TIPRE00043815
- Category : Life Sciences
- No. of Pages : 236
- Available Report Formats :
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. Executive Summary
1.1 Analyst Market Outlook
1.2 Market Attractiveness
2. Colistin Market Landscape
2.1 Overview
2.2 Value Chain Analysis
2.3 Supply Chain Analysis
2.3.1 List of Manufacturers/Suppliers
2.3.2 List of Potential Customers (Upto 50)
2.4 Porter's Five Forces Analysis
2.5 PEST Analysis
3. Competitive Landscape
3.1 Company Benchmarking by Key Players
3.2 Market Share Analysis, 2025 - By Key Players
3.3 Market Concentration
4. Europe Colistin Market - Key Industry Dynamics
4.1 Market Drivers
4.2 Market Restraints
4.3 Market Opportunities
4.4 Future Trends
4.5 Impact of Drivers and Restraints:
5. Colistin Market - Europe Analysis
5.1 Europe Colistin Market Revenue (US$ Million), 2021 - 2034
5.2 Europe Colistin Market Revenue Forecast and Analysis
6. Europe Colistin Market Revenue Analysis - by Formulation
6.1 Europe Colistin Market Forecast and Analysis by Formulation
6.1.1 Injectables (IV or IM)
6.1.1.1 Overview
6.1.1.2 Injectables (IV or IM): Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
6.1.2 Oral
6.1.2.1 Overview
6.1.2.2 Oral: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
6.1.3 Topical Formulations
6.1.3.1 Overview
6.1.3.2 Topical Formulations: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
6.1.4 Inhalation Solutions
6.1.4.1 Overview
6.1.4.2 Inhalation Solutions: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
7. Europe Colistin Market Revenue Analysis - by Indication
7.1 Europe Colistin Market Forecast and Analysis by Indication
7.1.1 Human Health
7.1.1.1 Overview
7.1.1.2 Human Health: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
7.1.2 Animal Health
7.1.2.1 Overview
7.1.2.2 Animal Health: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
8. Europe Colistin Market Revenue Analysis - by Human Health
8.1 Europe Colistin Market Forecast and Analysis by Human Health
8.1.1 Bloodstream Infections (BSI) and Sepsis Lower
8.1.1.1 Overview
8.1.1.2 Bloodstream Infections (BSI) and Sepsis Lower: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
8.1.2 Respiratory Tract Infections (LRTI)
8.1.2.1 Overview
8.1.2.2 Respiratory Tract Infections (LRTI): Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
8.1.3 Urinary Tract Infections (UTIs)
8.1.3.1 Overview
8.1.3.2 Urinary Tract Infections (UTIs): Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
8.1.4 Central Nervous System Infections
8.1.4.1 Overview
8.1.4.2 Central Nervous System Infections: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
8.1.5 Skin Infections
8.1.5.1 Overview
8.1.5.2 Skin Infections: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
8.1.6 Cystic Fibrosis
8.1.6.1 Overview
8.1.6.2 Cystic Fibrosis: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
8.1.7 Tracheobronchitis or VAP
8.1.7.1 Overview
8.1.7.2 Tracheobronchitis or VAP: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
8.1.8 Gastrointestinal Infections
8.1.8.1 Overview
8.1.8.2 Gastrointestinal Infections: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
8.1.9 Bowel Decontamination
8.1.9.1 Overview
8.1.9.2 Bowel Decontamination: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
9. Europe Colistin Market Revenue Analysis - by Distribution Channel
9.1 Europe Colistin Market Forecast and Analysis by Distribution Channel
9.1.1 Hospital Pharmacy
9.1.1.1 Overview
9.1.1.2 Hospital Pharmacy: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
9.1.2 Retail Pharmacy
9.1.2.1 Overview
9.1.2.2 Retail Pharmacy: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
9.1.3 Online Channel
9.1.3.1 Overview
9.1.3.2 Online Channel: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
9.1.4 Other Distribution Channel
9.1.4.1 Overview
9.1.4.2 Other Distribution Channel: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
10. Europe Colistin Market - Country Analysis
10.1 Europe
10.1.1 Europe Colistin Market Forecast and Analysis - by Country
10.1.1.1 Germany Market
10.1.1.1.1 Germany: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
10.1.1.1.2 Germany: Europe Colistin Market - By Segmentation
10.1.1.1.2.1 Formulation
10.1.1.1.2.2 Indication
10.1.1.1.2.3 Human Health
10.1.1.1.2.4 Distribution Channel
10.1.1.2 United Kingdom Market
10.1.1.2.1 United Kingdom: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
10.1.1.2.2 United Kingdom: Europe Colistin Market - By Segmentation
10.1.1.2.2.1 Formulation
10.1.1.2.2.2 Indication
10.1.1.2.2.3 Human Health
10.1.1.2.2.4 Distribution Channel
10.1.1.3 France Market
10.1.1.3.1 France: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
10.1.1.3.2 France: Europe Colistin Market - By Segmentation
10.1.1.3.2.1 Formulation
10.1.1.3.2.2 Indication
10.1.1.3.2.3 Human Health
10.1.1.3.2.4 Distribution Channel
10.1.1.4 Italy Market
10.1.1.4.1 Italy: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
10.1.1.4.2 Italy: Europe Colistin Market - By Segmentation
10.1.1.4.2.1 Formulation
10.1.1.4.2.2 Indication
10.1.1.4.2.3 Human Health
10.1.1.4.2.4 Distribution Channel
10.1.1.5 Spain Market
10.1.1.5.1 Spain: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
10.1.1.5.2 Spain: Europe Colistin Market - By Segmentation
10.1.1.5.2.1 Formulation
10.1.1.5.2.2 Indication
10.1.1.5.2.3 Human Health
10.1.1.5.2.4 Distribution Channel
10.1.1.6 Poland Market
10.1.1.6.1 Poland: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
10.1.1.6.2 Poland: Europe Colistin Market - By Segmentation
10.1.1.6.2.1 Formulation
10.1.1.6.2.2 Indication
10.1.1.6.2.3 Human Health
10.1.1.6.2.4 Distribution Channel
10.1.1.7 Romania Market
10.1.1.7.1 Romania: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
10.1.1.7.2 Romania: Europe Colistin Market - By Segmentation
10.1.1.7.2.1 Formulation
10.1.1.7.2.2 Indication
10.1.1.7.2.3 Human Health
10.1.1.7.2.4 Distribution Channel
10.1.1.8 Serbia Market
10.1.1.8.1 Serbia: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
10.1.1.8.2 Serbia: Europe Colistin Market - By Segmentation
10.1.1.8.2.1 Formulation
10.1.1.8.2.2 Indication
10.1.1.8.2.3 Human Health
10.1.1.8.2.4 Distribution Channel
10.1.1.9 Bulgaria Market
10.1.1.9.1 Bulgaria: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
10.1.1.9.2 Bulgaria: Europe Colistin Market - By Segmentation
10.1.1.9.2.1 Formulation
10.1.1.9.2.2 Indication
10.1.1.9.2.3 Human Health
10.1.1.9.2.4 Distribution Channel
10.1.1.10 Czech Republic Market
10.1.1.10.1 Czech Republic: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
10.1.1.10.2 Czech Republic: Europe Colistin Market - By Segmentation
10.1.1.10.2.1 Formulation
10.1.1.10.2.2 Indication
10.1.1.10.2.3 Human Health
10.1.1.10.2.4 Distribution Channel
10.1.1.11 Belgium Market
10.1.1.11.1 Belgium: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
10.1.1.11.2 Belgium: Europe Colistin Market - By Segmentation
10.1.1.11.2.1 Formulation
10.1.1.11.2.2 Indication
10.1.1.11.2.3 Human Health
10.1.1.11.2.4 Distribution Channel
10.1.1.12 Slovakia Market
10.1.1.12.1 Slovakia: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
10.1.1.12.2 Slovakia: Europe Colistin Market - By Segmentation
10.1.1.12.2.1 Formulation
10.1.1.12.2.2 Indication
10.1.1.12.2.3 Human Health
10.1.1.12.2.4 Distribution Channel
10.1.1.13 Ireland Market
10.1.1.13.1 Ireland: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
10.1.1.13.2 Ireland: Europe Colistin Market - By Segmentation
10.1.1.13.2.1 Formulation
10.1.1.13.2.2 Indication
10.1.1.13.2.3 Human Health
10.1.1.13.2.4 Distribution Channel
10.1.1.14 Hungary Market
10.1.1.14.1 Hungary: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
10.1.1.14.2 Hungary: Europe Colistin Market - By Segmentation
10.1.1.14.2.1 Formulation
10.1.1.14.2.2 Indication
10.1.1.14.2.3 Human Health
10.1.1.14.2.4 Distribution Channel
10.1.1.15 Portugal Market
10.1.1.15.1 Portugal: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
10.1.1.15.2 Portugal: Europe Colistin Market - By Segmentation
10.1.1.15.2.1 Formulation
10.1.1.15.2.2 Indication
10.1.1.15.2.3 Human Health
10.1.1.15.2.4 Distribution Channel
10.1.1.16 Lithuania Market
10.1.1.16.1 Lithuania: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
10.1.1.16.2 Lithuania: Europe Colistin Market - By Segmentation
10.1.1.16.2.1 Formulation
10.1.1.16.2.2 Indication
10.1.1.16.2.3 Human Health
10.1.1.16.2.4 Distribution Channel
10.1.1.17 Austria Market
10.1.1.17.1 Austria: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
10.1.1.17.2 Austria: Europe Colistin Market - By Segmentation
10.1.1.17.2.1 Formulation
10.1.1.17.2.2 Indication
10.1.1.17.2.3 Human Health
10.1.1.17.2.4 Distribution Channel
10.1.1.18 Bosnia and Herzegovina Market
10.1.1.18.1 Bosnia and Herzegovina: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
10.1.1.18.2 Bosnia and Herzegovina: Europe Colistin Market - By Segmentation
10.1.1.18.2.1 Formulation
10.1.1.18.2.2 Indication
10.1.1.18.2.3 Human Health
10.1.1.18.2.4 Distribution Channel
10.1.1.19 Latvia Market
10.1.1.19.1 Latvia: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
10.1.1.19.2 Latvia: Europe Colistin Market - By Segmentation
10.1.1.19.2.1 Formulation
10.1.1.19.2.2 Indication
10.1.1.19.2.3 Human Health
10.1.1.19.2.4 Distribution Channel
10.1.1.20 Netherlands Market
10.1.1.20.1 Netherlands: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
10.1.1.20.2 Netherlands: Europe Colistin Market - By Segmentation
10.1.1.20.2.1 Formulation
10.1.1.20.2.2 Indication
10.1.1.20.2.3 Human Health
10.1.1.20.2.4 Distribution Channel
10.1.1.21 Greece Market
10.1.1.21.1 Greece: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
10.1.1.21.2 Greece: Europe Colistin Market - By Segmentation
10.1.1.21.2.1 Formulation
10.1.1.21.2.2 Indication
10.1.1.21.2.3 Human Health
10.1.1.21.2.4 Distribution Channel
10.1.1.22 Rest of Europe Market
10.1.1.22.1 Rest of Europe: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
10.1.1.22.2 Rest of Europe: Europe Colistin Market - By Segmentation
10.1.1.22.2.1 Formulation
10.1.1.22.2.2 Indication
10.1.1.22.2.3 Human Health
10.1.1.22.2.4 Distribution Channel
11 Colistin Market Industry Landscape
12 - Key Company Profiles
12.1 Livzon Pharmaceutical Group Inc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 TZF Polfa S.A.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Tecoland Corporation
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Fujian lifecome biochemistry Limited
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Zhejiang Shenghua Biok Chemical Company Limited
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Xellia Pharmaceuticals ApS
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Shandong LuKang Pharmaceutical Co., Ltd
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Apeloa Pharmaceutical Co., Ltd.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Norma Hellas S.A
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Hebei Shengxue Dacheng Pharmaceutical Co., Ltd
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 Glossary
13.4 Research Methodology and Approach
13.4.1 Secondary Research
13.4.2 Primary Research
13.4.3 Market Estimation Approach
13.4.3.1 Supply Side Analysis
13.4.3.2 Demand Side Analysis
13.4.4 Research Assumptions and Limitations
13.4.5 Currency Conversion
13.5 About The Insight Partners
13.6 Market Intelligence Cloud
List of Tables
Table 1. Europe Colistin Market Segmentation
Table 5. Market Share Analysis, 2025 - By Key Players
Table 6. Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
Table 7. Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Formulation
Table 8. Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Indication
Table 9. Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Human Health
Table 10. Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Distribution Channel
Table 11. Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
Table 12. Germany: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Formulation
Table 13. Germany: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Indication
Table 14. Germany: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Human Health
Table 15. Germany: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Distribution Channel
Table 16. United Kingdom: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Formulation
Table 17. United Kingdom: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Indication
Table 18. United Kingdom: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Human Health
Table 19. United Kingdom: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Distribution Channel
Table 20. France: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Formulation
Table 21. France: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Indication
Table 22. France: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Human Health
Table 23. France: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Distribution Channel
Table 24. Italy: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Formulation
Table 25. Italy: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Indication
Table 26. Italy: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Human Health
Table 27. Italy: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Distribution Channel
Table 28. Spain: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Formulation
Table 29. Spain: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Indication
Table 30. Spain: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Human Health
Table 31. Spain: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Distribution Channel
Table 32. Poland: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Formulation
Table 33. Poland: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Indication
Table 34. Poland: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Human Health
Table 35. Poland: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Distribution Channel
Table 36. Romania: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Formulation
Table 37. Romania: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Indication
Table 38. Romania: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Human Health
Table 39. Romania: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Distribution Channel
Table 40. Serbia: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Formulation
Table 41. Serbia: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Indication
Table 42. Serbia: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Human Health
Table 43. Serbia: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Distribution Channel
Table 44. Bulgaria: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Formulation
Table 45. Bulgaria: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Indication
Table 46. Bulgaria: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Human Health
Table 47. Bulgaria: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Distribution Channel
Table 48. Czech Republic: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Formulation
Table 49. Czech Republic: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Indication
Table 50. Czech Republic: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Human Health
Table 51. Czech Republic: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Distribution Channel
Table 52. Belgium: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Formulation
Table 53. Belgium: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Indication
Table 54. Belgium: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Human Health
Table 55. Belgium: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Distribution Channel
Table 56. Slovakia: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Formulation
Table 57. Slovakia: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Indication
Table 58. Slovakia: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Human Health
Table 59. Slovakia: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Distribution Channel
Table 60. Ireland: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Formulation
Table 61. Ireland: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Indication
Table 62. Ireland: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Human Health
Table 63. Ireland: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Distribution Channel
Table 64. Hungary: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Formulation
Table 65. Hungary: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Indication
Table 66. Hungary: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Human Health
Table 67. Hungary: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Distribution Channel
Table 68. Portugal: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Formulation
Table 69. Portugal: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Indication
Table 70. Portugal: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Human Health
Table 71. Portugal: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Distribution Channel
Table 72. Lithuania: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Formulation
Table 73. Lithuania: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Indication
Table 74. Lithuania: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Human Health
Table 75. Lithuania: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Distribution Channel
Table 76. Austria: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Formulation
Table 77. Austria: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Indication
Table 78. Austria: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Human Health
Table 79. Austria: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Distribution Channel
Table 80. Bosnia and Herzegovina: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Formulation
Table 81. Bosnia and Herzegovina: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Indication
Table 82. Bosnia and Herzegovina: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Human Health
Table 83. Bosnia and Herzegovina: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Distribution Channel
Table 84. Latvia: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Formulation
Table 85. Latvia: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Indication
Table 86. Latvia: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Human Health
Table 87. Latvia: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Distribution Channel
Table 88. Netherlands: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Formulation
Table 89. Netherlands: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Indication
Table 90. Netherlands: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Human Health
Table 91. Netherlands: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Distribution Channel
Table 92. Greece: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Formulation
Table 93. Greece: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Indication
Table 94. Greece: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Human Health
Table 95. Greece: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Distribution Channel
Table 96. Rest of Europe: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Formulation
Table 97. Rest of Europe: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Indication
Table 98. Rest of Europe: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Human Health
Table 99. Rest of Europe: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million) - by Distribution Channel
Table 100. Glossary - Europe Colistin Market
List of Figures
Figure 1. Europe Colistin Market - Value Chain Analysis
Figure 2. Porter's Five Forces Analysis
Figure 3. PEST Analysis
Figure 4. Europe Colistin Market - Key Industry Dynamics
Figure 5. Impact Analysis of Drivers and Restraints
Figure 6. Europe Colistin Market Revenue (US$ Million), 2021 - 2034
Figure 7. Europe Colistin Market Share (%) - by Formulation, 2025 and 2034
Figure 8. Injectables (IV or IM): Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
Figure 9. Oral: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
Figure 10. Topical Formulations: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
Figure 11. Inhalation Solutions: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
Figure 12. Europe Colistin Market Share (%) - by Indication, 2025 and 2034
Figure 13. Human Health: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
Figure 14. Animal Health: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
Figure 15. Europe Colistin Market Share (%) - by Human Health, 2025 and 2034
Figure 16. Bloodstream Infections (BSI) and Sepsis Lower: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
Figure 17. Respiratory Tract Infections (LRTI): Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
Figure 18. Urinary Tract Infections (UTIs): Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
Figure 19. Central Nervous System Infections: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
Figure 20. Skin Infections: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
Figure 21. Cystic Fibrosis: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
Figure 22. Tracheobronchitis or VAP: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
Figure 23. Gastrointestinal Infections: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
Figure 24. Bowel Decontamination: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
Figure 25. Europe Colistin Market Share (%) - by Distribution Channel, 2025 and 2034
Figure 26. Hospital Pharmacy: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
Figure 27. Retail Pharmacy: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
Figure 28. Online Channel: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
Figure 29. Other Distribution Channel: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
Figure 30. Europe Colistin Market Breakdown by Key Countries, 2025 and 2034 (%)
Figure 31. Germany: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
Figure 32. United Kingdom: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
Figure 33. France: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
Figure 34. Italy: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
Figure 35. Spain: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
Figure 36. Poland: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
Figure 37. Romania: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
Figure 38. Serbia: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
Figure 39. Bulgaria: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
Figure 40. Czech Republic: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
Figure 41. Belgium: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
Figure 42. Slovakia: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
Figure 43. Ireland: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
Figure 44. Hungary: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
Figure 45. Portugal: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
Figure 46. Lithuania: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
Figure 47. Austria: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
Figure 48. Bosnia and Herzegovina: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
Figure 49. Latvia: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
Figure 50. Netherlands: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
Figure 51. Greece: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
Figure 52. Rest of Europe: Europe Colistin Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
Figure 53. Bottom-Up Approach and Top-Down Approach
Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.
Absolutely - analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.
Once your order is successfully placed, you will receive a confirmation email along with your invoice.
• For published reports: You'll receive access to the report within 4-6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.
We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we'll be happy to provide a customized proposal or scope.
The report is available in either PDF format or as an Excel dataset, depending on the license you choose.
The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.
Our payment process is fully secure and PCI-DSS compliant.
We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.
Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we're happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you're considering, and we'll share a personalized quote.
Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report's scope, methodology, customization options, or which license suits you best, we're here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.
Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we'll be happy to assist.
Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we'll ensure the issue is resolved quickly so you can access your report without interruption.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For